Goodwin Strengthens Life Sciences Public M&A Bench With Partner Richard Schwartz

Global law firm Goodwin today announced that Richard (Richie) Schwartz has joined the firm as a partner in its Life Sciences group and Public M&A practice in the Boston office.

“Richie brings a strong combination of public M&A experience, strategic judgment, and boardroom perspective that will further strengthen our ability to help clients execute complex public company transactions and navigate critical governance issues,” said Joshua Zachariah, Chair of Global M&A and partner at Goodwin. “We remain focused on building the talent and capabilities to help our clients move with confidence. We are excited to welcome Richie to Goodwin.”

Richie advises boards, management teams, and investors on complex public M&A transactions, including domestic and cross-border transactions, carve-outs, and spinoffs. He also advises clients on corporate governance matters and the evaluation of strategic alternatives.

Goodwin is a global leader in mergers and acquisitions, advising clients on more transactions annually than any other law firm worldwide. Its M&A team includes more than 600 lawyers across North America, Europe, and Asia, combining deep industry knowledge with a commercial approach to execute complex domestic and cross-border transactions. The firm represents public and private companies, private equity and venture capital firms, founders, investors, and financial advisors across the full spectrum of M&A matters, supported by leading litigation, restructuring, tax, and insurance capabilities. Goodwin’s market-leading experience spans key sectors including private equity, technology, life sciences, real estate, financial services, healthcare, and hospitality.